Raymond James Financial Services Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,293
| Closed | -$11K | – | 3444 |
|
|
2023
Q4 | $11K | Buy |
+1,293
| New | +$11K | ﹤0.01% | 3247 |
|
|
2020
Q1 | – | Sell |
-632
| Closed | -$205K | – | 2663 |
|
|
2019
Q4 | $205K | Sell |
632
-438
| -41% | -$142K | ﹤0.01% | 2553 |
|
|
2019
Q3 | $292K | Buy |
1,070
+367
| +52% | +$100K | ﹤0.01% | 2264 |
|
|
2019
Q2 | $375K | Buy |
703
+88
| +14% | +$46.9K | ﹤0.01% | 2115 |
|
|
2019
Q1 | $310K | Buy |
615
+164
| +36% | +$82.7K | ﹤0.01% | 2220 |
|
|
2018
Q4 | $222K | Buy |
451
+160
| +55% | +$78.8K | ﹤0.01% | 2189 |
|
|
2018
Q3 | $266K | Buy |
291
+5
| +2% | +$4.57K | ﹤0.01% | 2349 |
|
|
2018
Q2 | $209K | Buy |
286
+116
| +68% | +$84.8K | ﹤0.01% | 2446 |
|
|
2018
Q1 | $270K | Buy |
+170
| New | +$270K | ﹤0.01% | 2087 |
|